Skip to main content
logo
Cardiol Therapeutics Inc. (TSX:CRDL)
Canada flag Canada · Delayed Price · Currency is CAD
2.030
+0.040 (2.01%)
Aug 10, 2026, 12:33 PM EST

Cardiol Therapeutics Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-36.35-33.82-36.68-28.13-30.93-31.64
Depreciation & Amortization
0.10.10.370.250.220.22
Asset Writedown & Restructuring Costs
----1.360.08
Stock-Based Compensation
11.410.714.284.175.5412.61
Other Operating Activities
1.09-0.11-2.1-0.93-9.15-4.89
Change in Accounts Receivable
0.010.040.040.07-0.14-0.06
Change in Inventory
-----0.02
Change in Accounts Payable
1.150.26-1.06-1.294.472.39
Change in Other Net Operating Assets
-1.62-1.040.090.681.42-2.27
Operating Cash Flow
-24.22-23.85-25.06-25.18-27.22-23.54
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.06-0.02-0.02-0.06-0.07-0.01
Investing Cash Flow
-0.06-0.02-0.02-0.06-0.07-0.01

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.06-0.04-0.06-0.05-0.05
Net Debt Issued (Repaid)
-0.06-0.06-0.04-0.06-0.05-0.05
Issuance of Common Stock
30.9216.0721.53--98.72
Other Financing Activities
-1.71-0.48-2.65---5.23
Financing Cash Flow
29.1515.5418.84-0.06-0.0593.44

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.49-0.821.890.762.92-0.01
Net Cash Flow
4.38-9.16-4.35-24.54-24.4369.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-24.28-23.88-25.08-25.24-27.3-23.55
Free Cash Flow Growth
------
Free Cash Flow Margin
------29904.22%
Free Cash Flow Per Share
-0.26-0.28-0.35-0.39-0.44-0.55
Levered Free Cash Flow
-13.05-13.03-11.71-14.99-20.64-4.61
Unlevered Free Cash Flow
-13.05-13.03-11.71-14.99-20.64-4.61

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.46-0.73-0.93-0.555.750.08